The investment seeks capital appreciation.
The fund seeks to achieve its investment objective primarily by investing in long and short positions in equity securities of U.S. and foreign companies listed on U.S. stock exchanges in an attempt to benefit from rising markets and hedge against falling markets. The fund's investments may include common stock, preferred stock, investments in foreign equity securities through U.S. stock exchange listed ADRs and ETFs. The fund may invest in companies of any market capitalization. Its investments in foreign securities will primarily be in companies in developed countries.
The investment seeks to track the price and yield performance, before fees and expenses, of the Scientific Beta United States Multi-Beta Multi-Strategy Equal Weight Index.
Under normal circumstances, at least 80% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The fund may invest the remainder of its assets in cash and cash equivalents, such as repurchase agreements or money market instruments, or other instruments that Vident Investment Advisory, LLC, the sub-adviser to the fund, believes will help the fund track the index.
The investment seeks to replicate, net of expenses, the CBOE S&P 500 BuyWrite Index.
The index is designed to measure the total rate of return of a hypothetical “buy-write”, or “covered call”, strategy on the S&P 500 Index. This strategy consists of a hypothetical portfolio consisting of a “long” position indexed to the S&P 500 Index and the sale of a succession of one-month, at- or slightly out-of-the-money
S&P 500 Index call options that are listed on the Chicago Board Options Exchange.